OncoVeryx: Detection Of 30 Cancers In Both Women And Men

OncoVeryx aims to provide early and precise detection of cancers in asymptomatic and high risk women and men. The test utilizes

advanced LC/MS-MS technologies to screen for 30 cancers from a single blood draw. Notably, in positive cases, the test can identify

the tissue of origin among 21 different types. Through extensive research and technological advancements, we are dedicated to developing

a highly accurate and reliable test that can significantly improve early intervention and treatment outcomes. Join us in the future of cancer

diagnostics with our innovative  comprehensive OncoVeryx Test Portfolio.